Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
BRIACELL THERAPEUTICS CORP.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Fees to Be Paid | Equity | Units consisting of (1)(2) | 457(o) | $ | 25,000,000 | $ | 0.00013810 | $ | 3,452.50 | |||||||||||||||||
| Fees to Be Paid | Equity | (i) Common Shares, no par value | 457(o) | - | 0.00013810- | 0- | ||||||||||||||||||||
| Fees to Be Paid | Equity | (ii) One Warrant to Purchase One Common Share (3) | 457(o) | - | 0.00013810- | 0- | ||||||||||||||||||||
| Fees to Be Paid | Equity | Common Shares Underlying Warrants | 457(o) | $ | 32,812,500 | (4) | $ | 0.00013810 | 4,531.40 | |||||||||||||||||
| Fees to Be Paid | Equity | Pre-funded Units consisting of (1)(2) | 457(o) | - | 0.00013810- | 0(2 | ) | |||||||||||||||||||
| Fees to Be Paid | Equity | (i) Common Shares (3) | 457(o) | - | 0.00013810- | 0- | ||||||||||||||||||||
| Fees to Be Paid | Equity | (ii) Pre-Funded Warrants to Purchase Common Shares (3) | 457(o) | - | 0.00013810- | 0(2 | ) | |||||||||||||||||||
| Fees to Be Paid | Equity | Common Shares Underlying Pre-Funded Warrants (2) | 457(o) | - | 0.00013810- | 0(2 | ) | |||||||||||||||||||
| Fees to Be Paid | Equity | Placement Agent Warrants to Purchase Common Shares | 457(o) | - | 0.00013810- | 0(3 | ) | |||||||||||||||||||
| Total Offering Amounts | 57,812,500 | $ | 7,983.90 | |||||||||||||||||||||||
| Total Fees Previously Paid | - | $ | - | |||||||||||||||||||||||
| Total Fee Offsets | - | $ | - | |||||||||||||||||||||||
| Net Fee Due | 7,983.90 | $ | 7,983.90 | |||||||||||||||||||||||
| (1) | This registration statement also includes an indeterminate number of securities that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”). |
| (2) | The proposed maximum aggregate offering price of the Units will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-funded Units issued in the offering, and the proposed maximum aggregate offering price of the Pre-funded Units to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Units issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Units and Pre-funded Units (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $25,000,000. |
| (3) | No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act. |
| (4) | As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the shares underlying the Warrants (including Placement Agent’s Warrants) is equal to $32,902,500 (which is equal to the proposed maximum aggregate offering price for the Units of $25,000,000 multiplied by 125% plus the maximum aggregate offering price of the shares underlying the Placement Agent’s Warrants). |
N/A